Virtual Medicinal Product (VMP)
-
Polatuzumab vedotin 30mg powder for solution for infusion vials
Name Details
Current Name
Polatuzumab vedotin 30mg powder for solution for infusion vials
|
Start Date
28-01-2021
|
End Date
|
|
Abbreviated Name
Polatuzumab vedotin 30mg inf vials
|
Start Date
28-01-2021
|
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Powder for solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01FX14
SNOMED Codes
Code
|
Start Date
|
End Date
|
39355911000001109 |
28-01-2021 |
|
VMP Ingredients
Name
Polatuzumab vedotin
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
30.0
Strength and UOM (Dmr)
Virtual Medicinal Product Pack (VMPP) Information